|
| 2023, Vol. 33(02): 156-161 DOI: | ||
| Clinical characteristics of 26 cases with endocrine gland diseases related to programmed death receptor-1 (PD1) inhibitors in cancer patients | ||
| WANG Qun1, JIANG Jinjin2, LU Zhiqiang2, ZHAO Lin2 | ||
| (1. Department of Endocrinology, the Fourth Affiliated Hospital of Nanjing Medical University, Nanjing Jiangsu 210000； 2. Department of Endocrinology, Zhongshan Hospital, Fudan University, Shanghai 200032, China) |
||
| Received 2022-08-02 Revised null | ||
| Supporting info | ||
|